JLE

European Journal of Dermatology

MENU

Treatment of recalcitrant erythrodermic psoriasis with ustekinumab Volume 24, issue 3, May-June 2014

Tables

Authors
1 Institute of Dermatology,
Ospedale “San Michele”.
Piazza Rodolone, 1
33013-Gemona del Friuli (Udine), Italy
2 SOC Dermatologia e Malattie Sessualmente Trasmesse,
San Carlo Hospital,
Potenza, Italy

Erythrodermic psoriasis (EP) can be challenging to treat since several factors, such as failure or intolerance, limit favourable outcomes with traditional therapies [1]. The conventional treatments recommended for EP are methotrexate, oral retinoids and cyclosporine [2], although systemic steroids are still used, especially in severe and unstable forms, since they usually induce a rapid clinical improvement [2, 3]. Recently, some cases of EP have been successfully treated with biological agents, [...]